REPL · Director Paolo Pucci filed a Form 144 notice of intent to sell 138,700…

Director Paolo Pucci filed a Form 144 notice of intent to sell 138,700 shares of Replimune Group, valued at approximately $2.83 million based on the filing date. The shares were acquired via stock option exercise. The sale represents a modest portion of the company's $1.6B market cap and is a routine insider transaction.

• Director Paolo Pucci filed Form 144 to sell 138,700 shares
• Estimated sale value: $2,833,987.75 based on filing date
• Shares acquired via stock option exercise on the same date
• Sale intended to be executed on NASDAQ through Morgan Stanley Smith Barney